BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 27469182)

  • 1. Gastrointestinal, Pancreatic, and Hepatobiliary Manifestations of Cystic Fibrosis.
    Sathe MN; Freeman AJ
    Pediatr Clin North Am; 2016 Aug; 63(4):679-98. PubMed ID: 27469182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal and Hepatobiliary Disease in Cystic Fibrosis.
    Gabel ME; Galante GJ; Freedman SD
    Semin Respir Crit Care Med; 2019 Dec; 40(6):825-841. PubMed ID: 31659728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Animal models of gastrointestinal and liver diseases. Animal models of cystic fibrosis: gastrointestinal, pancreatic, and hepatobiliary disease and pathophysiology.
    Olivier AK; Gibson-Corley KN; Meyerholz DK
    Am J Physiol Gastrointest Liver Physiol; 2015 Mar; 308(6):G459-71. PubMed ID: 25591863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of pancreatic, gastrointestinal and liver complications in adult cystic fibrosis.
    Munck A; Languepin J; Debray D; Lamireau T; Abely M; Huet F; Maudinas R; Michaud L; Mas E
    Rev Mal Respir; 2015 Jun; 32(6):566-85. PubMed ID: 26001957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gastrointestinal complications of adult patients with cystic fibrosis].
    Bargon J; Stein J; Dietrich CF; Müller U; Caspary WF; Wagner TO
    Z Gastroenterol; 1999 Aug; 37(8):739-49. PubMed ID: 10494610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystic fibrosis and fat malabsorption: Pathophysiology of the cystic fibrosis gastrointestinal tract and the impact of highly effective CFTR modulator therapy.
    McDonald CM; Reid EK; Pohl JF; Yuzyuk TK; Padula LM; Vavrina K; Altman K
    Nutr Clin Pract; 2024 Apr; 39 Suppl 1():S57-S77. PubMed ID: 38429959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic Fibrosis below the Diaphragm: Abdominal Findings in Adult Patients.
    Lavelle LP; McEvoy SH; Ni Mhurchu E; Gibney RG; McMahon CJ; Heffernan EJ; Malone DE
    Radiographics; 2015; 35(3):680-95. PubMed ID: 25910185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changing paradigms in the treatment of gastrointestinal complications of cystic fibrosis in the era of cystic fibrosis transmembrane conductance regulator modulators.
    Konrad J; Eber E; Stadlbauer V
    Paediatr Respir Rev; 2022 Jun; 42():9-16. PubMed ID: 33485777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal, liver, and pancreatic involvement in adult patients with cystic fibrosis.
    Modolell I; Alvarez A; Guarner L; De Gracia J; Malagelada JR
    Pancreas; 2001 May; 22(4):395-9. PubMed ID: 11345141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystic fibrosis from the gastroenterologist's perspective.
    Ooi CY; Durie PR
    Nat Rev Gastroenterol Hepatol; 2016 Mar; 13(3):175-85. PubMed ID: 26790364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic involvement in cystic fibrosis.
    Ozen Alahdab Y; Duman DG
    Minerva Med; 2016 Dec; 107(6):427-436. PubMed ID: 27425634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal pathophysiology and nutrition in cystic fibrosis.
    Ratchford TL; Teckman JH; Patel DR
    Expert Rev Gastroenterol Hepatol; 2018 Sep; 12(9):853-862. PubMed ID: 30019967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal complications of cystic fibrosis.
    Gelfond D; Borowitz D
    Clin Gastroenterol Hepatol; 2013 Apr; 11(4):333-42; quiz e30-1. PubMed ID: 23142604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Year in review 2020: Nutrition and gastrointestinal disease in cystic fibrosis.
    Sathe M; Sharma PB; Savant AP
    Pediatr Pulmonol; 2021 Oct; 56(10):3120-3125. PubMed ID: 34310872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on Cystic Fibrosis in Pediatric Patients.
    Lusman SS
    Curr Gastroenterol Rep; 2023 Nov; 25(11):308-315. PubMed ID: 37653358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal manifestations of cystic fibrosis: radiologic-pathologic correlation.
    Agrons GA; Corse WR; Markowitz RI; Suarez ES; Perry DR
    Radiographics; 1996 Jul; 16(4):871-93. PubMed ID: 8835977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of endocrine disease: Cystic fibrosis-related diabetes: novel pathogenic insights opening new therapeutic avenues.
    Barrio R
    Eur J Endocrinol; 2015 Apr; 172(4):R131-41. PubMed ID: 25336504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatobiliary complications of cystic fibrosis.
    Feranchak AP
    Curr Gastroenterol Rep; 2004 Jun; 6(3):231-9. PubMed ID: 15128491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Intestinal Microbiome and Cystic Fibrosis Transmembrane Conductance Regulator Modulators: Emerging Themes in the Management of Gastrointestinal Manifestations of Cystic Fibrosis.
    Karb DB; Cummings LC
    Curr Gastroenterol Rep; 2021 Aug; 23(10):17. PubMed ID: 34448955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cystic Fibrosis-Associated Gastrointestinal Disease in Neonates.
    Duong JT; Sellers ZM
    Neoreviews; 2023 Jul; 24(7):e414-e430. PubMed ID: 37391660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.